Akèy › Timè selil won piti desmoplastik › New York
Etid klinik pou Timè selil won piti desmoplastik nan New York
3 etid pou Timè selil won piti desmoplastik ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- New York Medical College, Valhalla
Ap rekriteFaz 2
Laj 12 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT04616560Lurbinectedin in FET-Fused Tumors
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 10 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05918640Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jan 12, 2026 · NCT04690374Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.